SCHEMBL4280060

SCHEMBL4280060

Clc1cccc(-n2ccc3c[c]ccc32)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.53
PIM1 P11309 1/20 0.53
PIM3 Q86V86 1/20 0.53
HPGD P15428 2/20 0.47
BIRC5 O15392 1/20 0.41
FGFR1 P11362 1/20 0.40
MGLL Q99685 1/20 0.37
NOTUM Q6P988 1/20 0.36
IDO1 P14902 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HCAR1 Q9BXC0 1/20 0.35
THRB P10828 2/20 0.34
HTR3E A5X5Y0 1/20 0.34
HTR3B O95264 1/20 0.34
TP53 P04637 1/20 0.34
CYP1A2 P05177 1/20 0.34
ADRB1 P08588 1/20 0.34
CYP3A4 P08684 1/20 0.34
HTR1A P08908 1/20 0.34
CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16720346 0.82 HPGDS (0.39) ROCK2PIM1PIM3HPGDBIRC5
SCHEMBL4265823 0.82 ALDH1A1 (0.41) ROCK2PIM1PIM3HPGDMGLL
SCHEMBL16719724 0.82 FGFR1 (0.40) ROCK2PIM1PIM3HPGDBIRC5
SCHEMBL16720329 0.81 BIRC5 (0.59) ROCK2PIM1PIM3BIRC5NOTUM
SCHEMBL695269 0.81 CDC7 (0.42) NOTUMDRD2
SCHEMBL146100 0.80 BIRC5 (0.44) ROCK2PIM1PIM3BIRC5NOTUM
SCHEMBL695277 0.80 ROCK2 (0.59) ROCK2PIM1PIM3HPGDFGFR1
SCHEMBL16719754 0.80 ROCK2 (0.46) ROCK2PIM1PIM3HPGDALDH1A1
SCHEMBL16719859 0.79 FGFR1 (0.43) FGFR1MGLLNOTUMALDH1A1CYP1A2
SCHEMBL16720434 0.79 BIRC5 (0.36) ROCK2PIM1PIM3HPGDBIRC5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3068758-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE The Wistar Institute Of Anatomy And Biology (US) 2016-09-21 EP disclosed
WO-2015073864-A1 EBNA1 INHIBITORS AND THEIR METHOD OF USE THE WISAR INSTITUTE OF ANATOMY AND BIOLOGY (US) 2015-05-21 WO disclosed
EP-2120569-A2 SPIROCHROMANON DERIVATIVES Merck & Co., Inc. (US) 2009-11-25 EP disclosed
WO-2008088692-A2 SPIROCHROMANON DERIVATIVES MERCK & CO., INC. (US) 2008-07-24 WO disclosed